Bayview Pharmacy is pleased to present a specially compounded topical gel formulation of Metformin HCl 5%/Progesterone 1%/Spironolactone 2%. This unique formulation is specifically designed to address a range of skin conditions, including acne, rosacea, and seborrheic dermatitis.

The Metformin HCl component of this formulation is an antihyperglycemic agent that works to reduce inflammation and enhance skin health. Progesterone, a hormone, contributes to the reduction of sebum production and inflammation. Spironolactone, an antiandrogen, also aids in reducing sebum production and inflammation.

This combination of active ingredients works synergistically to reduce inflammation, decrease sebum production, and improve overall skin health. It has proven to be an effective treatment for conditions such as acne, rosacea, and seborrheic dermatitis.

The formulation is a semisolid compound dispensed through a pump mechanism, which allows for easy and precise application on the skin. This targeted treatment ensures that the active ingredients are absorbed effectively in a gel-like consistency, providing optimal results.

If you have any queries about this formulation or how it can assist in treating your specific skin condition, please do not hesitate to contact us at Bayview Pharmacy. Our team is committed to helping you find the most suitable treatment for your skin condition.

Metformin HCl 5%/Progesterone 1%/Spironolactone 2% Topical Gel is a compounded formulation designed to address a range of health conditions. Metformin HCl, an oral antidiabetic medication, is used in the treatment of type 2 diabetes. Progesterone, a hormone, is utilized in the management of conditions such as abnormal uterine bleeding, endometriosis, and infertility. Spironolactone, a diuretic, is employed in the treatment of hypertension, edema, and congestive heart failure.

When combined in this unique formulation, Metformin HCl 5%/Progesterone 1%/Spironolactone 2% Topical Gel can help alleviate the symptoms of these conditions. However, it is crucial to understand that this formulation should not replace other prescribed medications for these conditions, but rather serve as an adjunct treatment.

Patients should be aware that Metformin HCl 5%/Progesterone 1%/Spironolactone 2% Topical Gel may cause skin irritation, redness, or itching. If any of these side effects occur, it is recommended to contact a healthcare provider immediately.

Healthcare providers should be cognizant of potential interactions between Metformin HCl 5%/Progesterone 1%/Spironolactone 2% Topical Gel and other medications, including oral antidiabetic medications, hormones, and diuretics. Regular monitoring of patients' conditions is advised while they are on this medication.

If you have any questions or concerns about Metformin HCl 5%/Progesterone 1%/Spironolactone 2% Topical Gel, it is recommended to reach out to a healthcare provider or pharmacist for further information and guidance.

Metformin HCl 5%/Progesterone 1%/Spironolactone 2% Topical Gel is a compounded medication designed for targeted treatment of various skin conditions. This unique formulation combines three active ingredients: Metformin HCl, Progesterone, and Spironolactone, each with its own therapeutic benefits.

Metformin HCl, primarily known as an antidiabetic medication, plays a crucial role in this formulation by reducing blood sugar levels. When applied topically, it helps to decrease the production of glucose in the skin, thereby reducing inflammation.

Progesterone, a hormone that regulates the menstrual cycle, is used in this formulation to treat abnormal uterine bleeding. Topically, it aids in reducing the production of sebum, a substance that can cause skin irritation when produced in excess.

Spironolactone, a diuretic, is included in this formulation for its ability to reduce fluid retention. This property is beneficial in treating high blood pressure and, when applied topically, it can help reduce swelling in the skin.

This combination medication is designed to treat a variety of skin conditions, including acne, rosacea, and eczema. It is also effective in treating hirsutism, a condition characterized by excessive hair growth in women. The gel-like consistency of this formulation allows for easy and precise application on the skin, ensuring targeted treatment and absorption of the active ingredients.

Understanding the unique properties and benefits of each ingredient in this compounded formulation can help you better understand how it works to treat your specific skin condition. If you have any questions about this formulation, please don't hesitate to reach out for more information.

This Metformin HCl 5%/Progesterone 1%/Spironolactone 2% Topical Gel is a compounded formulation that has been effectively used in the treatment of a variety of conditions. It has been particularly beneficial in managing Polycystic Ovary Syndrome, Acne, Hirsutism, Hyperandrogenism, and Menopausal Symptoms. It has also shown efficacy in treating seborrheic dermatitis, alopecia, androgenic alopecia, and hirsutism.

Moreover, this formulation has been instrumental in reducing the risk of developing several conditions. It has been used to decrease the likelihood of ovarian cysts, endometrial hyperplasia, and endometrial cancer. It has also been beneficial in reducing the risk of acne, hirsutism, and hyperandrogenism.

Furthermore, this formulation has been used to mitigate the risk of developing menopausal symptoms, depression, and anxiety. It is dispensed through a pump mechanism, which allows for easy and precise application on the skin, ensuring targeted treatment or absorption of the active ingredients. If you have any questions about the use of this formulation, please do not hesitate to reach out.